Cover ImageSALE
市場調查報告書

腦神經血管內非線圈產品的全球市場:2016年∼2020年

Global Neuroendovascular Non-coils Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 379022
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
腦神經血管內非線圈產品的全球市場:2016年∼2020年 Global Neuroendovascular Non-coils Market 2016-2020
出版日期: 2016年10月13日 內容資訊: 英文 98 Pages
簡介

全球腦神經血管內非線圈產品市場預測在2016年∼2020年間,將以年複合成長率 (CAGR) 12.9%的速度成長。

本報告提供全球腦神經血管內非線圈產品市場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 波特的五力分析

第6章 腦神經血管內非線圈產品的全球市場:各類型產品

  • 腦神經血管內支架
  • 接入設備
  • 血流迂迴設備
  • 其他

第7章 腦神經血管內非線圈產品的全球市場:各地區

  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第8章 腦神經血管內非線圈產品的全球市場:推動因素

第9章 推動因素的影響

第10章 腦神經血管內非線圈產品的全球市場:課題

第11章 推動因素與課題的影響

第12章 腦神經血管內非線圈產品的全球市場:趨勢

第13章 業者情勢

  • 競爭模式
  • 主要新聞

第14章 主要供應商分析

  • DePuy Synthes
  • Medtronic
  • MicroVention
  • Stryker
  • 其他卓越供應商

第15章 附錄

第16章 關於Technavio

目錄
Product Code: IRTNTR10399

About Neuroendovascular Non-coils

A neuroendovascular non-coil is used to treat an unruptured or ruptured brain aneurysm (a weakened area in the artery wall). The treatment is either known as endovascular coiling or endovascular embolization. During this procedure, the neuroendovascular non-coil blocks the blood flow in an aneurysm. The treatment is usually performed under general anesthesia by interventional neuroradiologists using fluoroscopic imaging guidance. Neuroendovascular non-coils are used as alternatives to coils in the treatment of an aneurysm.

Technavio's analysts forecast the global neuroendovascular non-coils market to grow at a CAGR of 12.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global neuroendovascular non-coils market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of medical devices required for thoracic surgeries.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Neuroendovascular Non-coils Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Boston Scientific
  • Medtronic
  • Sorin
  • St. Jude Medical
  • Terumo

Other Prominent Vendors

  • Abiomed
  • AdvanSource Biomaterials
  • AGA Medical
  • Allium Medical
  • AngioDynamics
  • Angioslide
  • Atrium Medical
  • Biophan Technologies
  • Biosense Webster
  • Cardiac Science
  • CardiacAssist
  • Dextera Surgical
  • Cardio-Flow
  • Claret Medical
  • Contego Medical
  • Cook Group
  • Cryolife
  • Innovative Cardiovascular Solutions
  • Keystone Heart
  • St. Jude Medical
  • phenox
  • InspireMD
  • Acandis
  • Transverse Medical

Market driver

  • Rise in incidence of cardiac disorders and increase in aging population
  • For a full, detailed list, view our report

Market challenge

  • Potential complications associated with cardiac surgery
  • For a full, detailed list, view our report

Market trend

  • Growing popularity of robot-assisted cardiac surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Neuroendovascular diseases: An overview
  • Brain aneurysm
  • Endovascular embolization
  • Regulatory environment

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by product type

  • Neuroendovascular stents
  • Access devices
  • Flow diversion devices
  • Other neuroendovascular non-coil devices

PART 07: Geographical segmentation

  • Neuroendovascular non-coils market in Americas
  • Neuroendovascular non-coils market in EMEA
  • Neuroendovascular non-coils market in APAC

PART 08: Market drivers

  • High incidence rates of brain aneurysm and cerebral disorders
  • Growing demand for minimally invasive procedures with improved medical imaging
  • Rise in demand for intracranial stenting procedures
  • Rise in recognition and awareness

PART 09: Impact of drivers

PART 10: Market challenges

  • Shortage of skilled surgeons and technicians
  • High cost of stenting procedures
  • Complications associated with neuroendovascular procedures
  • Manufacturing hurdles and delay in product launch due to stringent regulatory approvals
  • Lack of adequate clinical evidence

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Increase in market penetration of non-coil devices through new technological advances
  • Growing surgeons' interests in adoption of flow diversion devices and neurovascular stents
  • Growing number of ongoing clinical trials
  • Transforming marketing and sales strategies for neuroendovascular non-coil devices

PART 13: Vendor landscape

  • Competitive scenario
  • Key news

PART 14: Key vendor analysis

  • DePuy Synthes
  • Medtronic
  • MicroVention
  • Stryker
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Neuroendovascular disease segments in 2014
  • Exhibit 03: Various treatment options available for neuroendovascular diseases
  • Exhibit 04: Neuroendovascular disease: New techniques and technologies
  • Exhibit 05: Comparison of flow diversion and endovascular coiling treatments for intracranial aneurysm based on different parameters
  • Exhibit 06: Series of patients with unruptured aneurysms
  • Exhibit 07: Methods of endovascular embolization for intracranial aneurysm treatment
  • Exhibit 08: Classification of medical devices by FDA
  • Exhibit 09: Snapshot of global neuroendovascular non-coils market
  • Exhibit 10: Snapshot of global neuroendovascular non-coils market
  • Exhibit 11: Global neuroendovascular non-coils market 2015-2020 ($ billions)
  • Exhibit 12: Global neuroendovascular non-coils market analysis: Developed and emerging markets
  • Exhibit 13: Global neuroendovascular non-coils market: Opportunity analysis
  • Exhibit 14: Five forces analysis
  • Exhibit 15: Global neuroendovascular non-coils market segmentation by product type 2015 and 2020
  • Exhibit 16: Global neuroendovascular non-coils market segmentation by product type 2015
  • Exhibit 17: Global neuroendovascular non-coils market segmentation by product type: Lifecycle analysis 2015
  • Exhibit 18: Commonly used ICD-9-CM diagnosis codes
  • Exhibit 19: Global neuroendovascular stents market 2015-2020 ($ millions)
  • Exhibit 20: Global neuroendovascular access devices market 2015-2020 ($ millions)
  • Exhibit 21: Number of flow diversion aneurysm procedures performed in 2013
  • Exhibit 22: Number of flow diversion aneurysm procedures performed in 2014
  • Exhibit 23: List of clinical trials for endovascular aneurysm and flow diversion treatment
  • Exhibit 24: Approved indications for flow diverters in US and Europe
  • Exhibit 25: Global neuroendovascular flow diversion devices market 2015-2020 ($ millions)
  • Exhibit 26: Clinical studies that showed positive results for embolic protection devices
  • Exhibit 27: Global other neuroendovascular non-coil devices market 2015-2020 ($ millions)
  • Exhibit 28: Neuroendovascular non-coils market segmentation by product type 2015-2020 ($ millions)
  • Exhibit 29: Neuroendovascular non-coils market segmentation by product type 2015-2020 (%)
  • Exhibit 30: Global neuroendovascular non-coils market segmentation by geography
  • Exhibit 31: Global neuroendovascular non-coils market: Geographical presence
  • Exhibit 32: Global neuroendovascular non-coils market segmentation by geography 2015
  • Exhibit 33: Global neuroendovascular non-coils market segmentation by geography 2015
  • Exhibit 34: Neuroendovascular non-coils market in Americas 2015-2020 ($ millions)
  • Exhibit 35: Neuroendovascular non-coils market in EMEA 2015-2020 ($ millions)
  • Exhibit 36: Neuroendovascular non-coils market in APAC 2015-2020 ($ millions)
  • Exhibit 37: Global neuroendovascular non-coils market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 38: Global neuroendovascular non-coils market segmentation by geography 2015-2020 (%)
  • Exhibit 39: Impact of drivers
  • Exhibit 40: Reported cases of rupture at later stage in large aneurysm (17 mm to 35 mm)
  • Exhibit 41: Five force analysis of global neuroendovascular non-coils market
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Few technological advancements related to neuroendovascular non-coil devices
  • Exhibit 44: Major ongoing clinical trials
  • Exhibit 45: Strategies of large and small neuroendovascular non-coil device manufacturers
  • Exhibit 46: Impacts of trends on global neuroendovascular non-coils market
  • Exhibit 47: Competitive structure analysis of global neuroendovascular non-coils market 2015
  • Exhibit 48: Market penetration of various manufacturers of neuroendovascular non-coils market 2015
  • Exhibit 49: Strategic success factors of companies in global neuroendovascular non-coils market
  • Exhibit 50: Presence of vendors in global neuroendovascular non-coils market
  • Exhibit 51: DePuy Synthes profile
  • Exhibit 52: DePuy Synthes strength analysis
  • Exhibit 53: DePuy Synthes growth strategy matrix
  • Exhibit 54: DePuy Synthes: Opportunity assessment
  • Exhibit 55: Medtronic profile
  • Exhibit 56: Medtronic strength analysis
  • Exhibit 57: Medtronic growth strategy matrix
  • Exhibit 58: Medtronic: Opportunity assessment
  • Exhibit 59: MicroVention profile
  • Exhibit 60: MicroVention strength analysis
  • Exhibit 61: MicroVention growth strategy matrix
  • Exhibit 62: MicroVention: Opportunity assessment
  • Exhibit 63: Stryker profile
  • Exhibit 64: Stryker strength analysis
  • Exhibit 65: Stryker growth strategy matrix
  • Exhibit 66: Stryker: Opportunity assessment
Back to Top